Monthly Archives: June 2014

URGENT – COMMENTS DEADLINE EXTENDED

The deadline for Myriad-Mayo comments has been extended by a month. Info on the USPTO website and can be found here.  

Posted in USPTO Practice and Policy | Tagged , , , , , , , , | Leave a comment

USPTO issues post- Alice examination guidelines

A copy of the guidelines can be found here: alice_pec_25jun2014 I will comment on this later.  

Posted in Patent Eligible Subject Matter | Tagged , , , , , , | Leave a comment

“We Don’t Need No Stinkin’ Patents” – Antibiotic and Antifungal Drugs Gain Non-Patent Exclusivity

Posted on the FDA Law Blog by Kurt Karst on June 19, 2014. After years of relative quiet, the Orange Book list of exclusivity terms has gotten quite a workout over the past year with the addition of several new terms … Continue reading

Posted in Hatch-Waxman | Tagged , , , , , , | Leave a comment

CLS v Alice – Abstract Idea, Wherefore Art Thou?

Guest post from Brad Forrest, Shareholder at Schwegman Lundberg & Woessner, P.A. Passing on the opportunity to provide a usable test to determine what is an “abstract idea,” the Supreme court simply compared the idea underlying the claims in Alice … Continue reading

Posted in Patent Eligible Subject Matter | Tagged , , , , , | 2 Comments